The present invention relates to peptidomimetics having a stable internally constrained protein secondary structure where the peptidomimetics contain a hydrogen bond surrogate in the internal constraint and at least one beta amino acid. Methods for promoting cell death using peptidomimetics that inhibit p53/hDM2 are also disclosed.
